Glucotrack Inc (GCTK)

Jun 05, 2025

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions - mx.advfn.com

Jun 05, 2025

Jun 04, 2025

GlucoTrack to Present at ADA Scientific Sessions - TipRanks

Jun 04, 2025

Jun 04, 2025

Revolutionary Diabetes Tech: Glucotrack's 3-Year Implantable Monitor Eliminates Daily Finger Pricks - Stock Titan

Jun 04, 2025

May 31, 2025

GCTK stock plunges to 52-week low, hits $0.13 By Investing.com - Investing.com South Africa

May 31, 2025

May 30, 2025

GCTK stock plunges to 52-week low, hits $0.13 - Investing.com Australia

May 30, 2025

May 29, 2025

Upcoming Benzinga Webinar With Glucotrack To Discuss The Potential Of Its Innovative CBGM Technology To Transform Diabetes Care And Patient Lives - The Globe and Mail

May 29, 2025

May 29, 2025

Glucotrack appoints new board member with diabetes tech expertise By Investing.com - Investing.com South Africa

May 29, 2025

May 28, 2025

Glucotrack appoints new board member with diabetes tech expertise - Investing.com

May 28, 2025

May 28, 2025

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD - The Manila Times

May 28, 2025

May 28, 2025

GlucoTrack (NASDAQ:GCTK) Trading Down 0.2% – Time to Sell? - Defense World

May 28, 2025

May 23, 2025

GlucoTrack Approves Key Proposals at Annual Meeting - TipRanks

May 23, 2025

May 22, 2025

GCTK stock plunges to 52-week low, touches $0.13 - Investing.com Australia

May 22, 2025

May 22, 2025

GCTK stock plunges to 52-week low, touches $0.13 By Investing.com - Investing.com Nigeria

May 22, 2025

May 20, 2025

GlucoTrack Establishes Patient Advisory Board for CBGM - TipRanks

May 20, 2025

May 20, 2025

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development - The Manila Times

May 20, 2025

May 20, 2025

Glucotrack, Inc. Forms Patient Advisory Board to Enhance Development of Continuous Blood Glucose Monitor - Nasdaq

May 20, 2025

May 20, 2025

Groundbreaking 3-Year Implantable Glucose Monitor Gets Patient-Led Development at Glucotrack - Stock Titan

May 20, 2025

May 16, 2025

Glucotrack Reports Q1 2025 Financial Results and Progress - TipRanks

May 16, 2025

May 15, 2025

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times

May 15, 2025

May 15, 2025

Innovative Continuous Blood Glucose Monitor Shows Promise in First Human Trial - citybuzz -

May 15, 2025

May 14, 2025

GlucoTrack Reports Q1 2025 Financial Results and Progress - TipRanks

May 14, 2025

May 14, 2025

Glucotrack, Inc. SEC 10-Q Report - TradingView

May 14, 2025

May 14, 2025

Glucotrack, Inc. Advances Continuous Blood Glucose Monitoring Technology with Clinical Study Initiation in Australia by Q3 2025 - Nasdaq

May 14, 2025

May 14, 2025

Glucotrack Reports First Quarter 2025 Financial Results And Recent Corporate Highlights - marketscreener.com

May 14, 2025

May 14, 2025

Breakthrough: Glucotrack's Implantable Diabetes Monitor Hits Clinical Milestone, FDA Decision Expected Q4 - Stock Titan

May 14, 2025

May 14, 2025

Glucotrack gains HREC approval for clinical study of CBGM device - Yahoo Finance

May 14, 2025

May 14, 2025

First-In-Human Study In The Bag, Glucotrack Gears Up For Long-Term Trial Of Potentially Groundbreaking Continuous Blood Glucose Monitor For Diabetes Patients - FinancialContent

May 14, 2025

May 13, 2025

Certain Options of GlucoTrack, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2025. - marketscreener.com

May 13, 2025

May 13, 2025

Certain Common Stock of GlucoTrack, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2025. - marketscreener.com

May 13, 2025

May 13, 2025

GlucoTrack Gains Approval for Long-Term Clinical Study - TipRanks

May 13, 2025

May 13, 2025

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor - The Manila Times

May 13, 2025

May 06, 2025

Geode Capital Management LLC Increases Stock Holdings in GlucoTrack, Inc. (NASDAQ:GCTK) - Defense World

May 06, 2025

Apr 30, 2025

GlucoTrack Inc (GCTK) can make a big difference with a little luck - Sete News

Apr 30, 2025

Apr 30, 2025

Medtech CEO Shares Lessons From FIH Implantable Glucose Monitor Trial - Clinical Leader

Apr 30, 2025

Apr 29, 2025

GlucoTrack Releases Investor Presentation on April 29 - TipRanks

Apr 29, 2025

Apr 29, 2025

GlucoTrack Inc (NASDAQ:GCTK) stock crossing the finish line today - uspostnews.com

Apr 29, 2025

Apr 29, 2025

Can GlucoTrack Inc Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

Apr 29, 2025

Apr 29, 2025

Now Is The Time To Build A Position In GlucoTrack Inc (NASDAQ:GCTK) - Marketing Sentinel

Apr 29, 2025

Apr 26, 2025

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights - ADVFN

Apr 26, 2025

Apr 22, 2025

It makes sense and dollars to buy GlucoTrack Inc (GCTK) stock - Sete News

Apr 22, 2025

Apr 18, 2025

Pre-market Movers: OPTN, WINT, AKBA, GCTK... - RTTNews

Apr 18, 2025

Apr 16, 2025

GlucoTrack Joins EU Bionic Pancreas Initiative - TipRanks

Apr 16, 2025

Apr 16, 2025

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas - The Manila Times

Apr 16, 2025

Apr 16, 2025

Major Breakthrough: Glucotrack Selected for EU's Revolutionary Bionic Pancreas Project - Stock Titan

Apr 16, 2025

Apr 16, 2025

Glucotrack to bring CBGM to bionic pancreas initiative in Europe - Drug Delivery Business

Apr 16, 2025

Apr 15, 2025

Investing in GlucoTrack Inc (GCTK) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com

Apr 15, 2025

Apr 07, 2025

GCTK stock plunges to 52-week low of $0.15 amid market turmoil By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

GCTK stock plunges to 52-week low of $0.15 amid market turmoil - Investing.com India

Apr 07, 2025

Apr 05, 2025

Glucotrack faces Nasdaq delisting over share price rule - Investing.com Australia

Apr 05, 2025